Old Web
English
Sign In
Acemap
>
authorDetail
>
Yann Hyvert
Yann Hyvert
Merck KGaA
Medicine
Cladribine
Internal medicine
Multiple sclerosis
Hazard ratio
3
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Concentration of evobrutinib, a BTK inhibitor, in cerebrospinal fluid during treatment of patients with relapsing multiple sclerosis in a phase 2 study
2021
Multiple sclerosis and related disorders
Karolina Piasecka-Stryczynska
Konrad Rejdak
Martin Dyroff
Yann Hyvert
Kristina Holmberg
Matthew Mandel
Carolina Cunha
David Mitchell
Emily Martin
Xavier Montalban
Show All
Source
Cite
Save
Citations (0)
Early MRI outcomes in participants with a first clinical demyelinating event at risk of multiple sclerosis in the ORACLE-MS study:
2021
Mark S. Freedman
Patricia K. Coyle
Giancarlo Comi
Susan Scarberry
Doris Damian
Yann Hyvert
Fernando Dangond
Andrew Galazka
Dominic Jack
Lori A Lebson
Thomas Leist
Show All
Source
Cite
Save
Citations (0)
Subgroup analysis of clinical and MRI outcomes in participants with a first clinical demyelinating event at risk of multiple sclerosis in the ORACLE-MS study
2020
Multiple sclerosis and related disorders
Bruce A. C. Cree
James D. Bowen
Hans-Peter Hartung
Patrick Vermersch
Bruce Hughes
Doris Damian
Yann Hyvert
Fernando Dangond
Andrew Galazka
Megan Grosso
Daniel L. Jones
Thomas Leist
Show All
Source
Cite
Save
Citations (2)
1
map